Article
Genotyping versus phenotyping of non-ABO erythrocyte antigens in patients with the Mediterranean hemopathic syndromes: Effect of transfusion therapy.
PloS one - 1 Jan 2021
NasrEldin Eman, Khaled Safaa A A, Abdelhameed Nada O, Atwa Maha, Thabet Marwa M, Elsayh Khalid I, Elgammal Sahar A
Abstract excerpt
The Mediterranean hemopathic syndromes (MHS) are the most prevalent hemoglobinopathies in the Mediterranean basin. Transfusion therapy is the main therapy for these disorders, particularly for severe forms of the disease. Currently, pre-transfusion serological typing of erythrocyte antigens is the standard tool for reducing complications of transfusion in those patients. This study compared genotyping with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.